Targeting ligands enhance internalization of polymeric nanoparticles in cancer cells.
TAT is exposed by shield/deshielding mechanism to avoid non-specific binding.
Tumor pH actives ligand-mediated delivery for tumor targeting.
Tumor pH triggers charge conversion to tumor cell uptake.
Polymeric nanoparticles have the potential to overcome resistance.